... strengths along with likely buyout speculation should propel ZGNX stock back over $6.00 for a healthy 3-bagger gain. For those reasons (and more to come in a second ZGNX article), Zogenix is my top biotech
NASDAQ
Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan …
Zogenix Inc. (NASDAQ:ZGNX)‘s stock had its “outperform” rating reissued by investment analysts at Leerink Swann in a report released on Tuesday. They currently have a $17.00 target price on the stock. Leerink …
Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, announced today that at the annual general meeting of …
That is because ZGNX recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom. What is a Hammer Chart Pattern? A hammer chart pattern is a popular technical indicator that is used in …
Liabilities: This item on the balance sheet implies the firm's, in this case Zogenix's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for ZGNX
They currently have a $28.00 PT on the company. Brean Capital’s target suggests a potential upside of 52.09% from the company’s last stock close price. NASDAQ:ZGNX is currently trading -2.02% lower at $18.41 as of …
Zogenix (ZGNX) has an average broker rating of 1.5, which is interpreted as a Strong Buy, as rated by 4 equity analysts. Nonetheless, 3 analysts are positive on the stocks future and they recommend a Strong Buy on the …
Zogenix, Inc. (NASDAQ:ZGNX)’s stock has been of interest for both individual investors and Wall Street analysts recently. Let’s look at the crowd and equity research sentiment so that we can get a solid idea as to where …
NASDAQ
Stock market analysts and brokers have recently amended their target prices on shares of Zogenix, Inc. (ZGNX). The most recent analyst ratings issued by brokerages: 11/11/2016 – Aegis Capital began new coverage on …